BCL2 and cancer: BCL-1, myeloid-cell leukemia (MCL-1), and B-cell lymphoma extralarge (BCL-XL) are antiapoptotic BCL-2 proteins frequently overexpressed in human cancer and protect cells against apoptosis under normal conditions in breast, prostate, and cholangiocarcinoma cancer cells [85–87].